Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Payables: 2019-2022

Historic Payables for ADC Therapeutics (ADCT) over the last 3 years, with Dec 2022 value amounting to $24.8 million.

  • ADC Therapeutics' Payables fell 3.21% to $23.3 million in Q3 2023 from the same period last year, while for Sep 2023 it was $95.9 million, marking a year-over-year increase of 46.13%. This contributed to the annual value of $24.8 million for FY2022, which is 105.50% up from last year.
  • Latest data reveals that ADC Therapeutics reported Payables of $24.8 million as of FY2022, which was up 105.50% from $12.1 million recorded in FY2021.
  • In the past 5 years, ADC Therapeutics' Payables ranged from a high of $24.8 million in FY2022 and a low of $3.3 million during FY2019.
  • Moreover, its 2-year median value for Payables was $18.5 million (2021), whereas its average is $18.5 million.
  • Data for ADC Therapeutics' Payables shows a peak YoY soared of 105.50% (in 2022) over the last 5 years.
  • ADC Therapeutics' Payables (Yearly) stood at $3.3 million in 2019, then reached $12.1 million in 2021, then skyrocketed by 105.50% to $24.8 million in 2022.